This review summarizes the pathophysiology, indications, procedural complications, and technological advancements in transcatheter pulmonary valve replacement.
May guide TPVR decision-making in congenital disease; leaves open need for prospective outcome trials.
The introduction of transcatheter therapy for valvular heart disease has changed the spectrum of care of patients with a variety of cardiovascular conditions. Transcatheter valve placement has become established as a method of treating pathologic regurgitation or stenosis of the pulmonary valve, right ventricular outflow tract or a right ventricle to pulmonary artery conduit. In this review, we examine the pathophysiology of and indications for transcatheter pulmonary valve replacement along with procedural complications. Advancements in clinical application and valve technology will also be covered.
No takes yet. Share an insight, caveat, or question.
Shahanavaz et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: